Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.980
-0.240 (-10.81%)
At close: Nov 21, 2024, 4:00 PM
2.000
+0.020 (1.01%)
After-hours: Nov 21, 2024, 5:42 PM EST
Mersana Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 245 | 280 | 585 | 447 | 1,823 | 274 | |
| Market Cap Growth | 51.50% | -52.15% | 30.71% | -75.46% | 564.32% | 190.08% | |
| Enterprise Value | 151 | 73 | 332 | 276 | 1,569 | 171 | |
| Last Close Price | 2.22 | 2.32 | 5.86 | 6.22 | 26.61 | 5.73 | |
| PS Ratio | 7.76 | 7.59 | 22.00 | 10402.13 | 2201.35 | 6.51 | |
| PB Ratio | 260.04 | 7.58 | 6.35 | 3.67 | 7.99 | 3.50 | |
| P/TBV Ratio | 221.03 | 7.58 | 6.35 | 3.67 | 7.99 | 3.50 | |
| EV/Sales Ratio | 4.32 | 1.99 | 12.48 | 6408.32 | 1894.81 | 4.06 | |
| Debt / Equity Ratio | 30.05 | 0.92 | 0.40 | 0.32 | 0.07 | 0.10 | |
| Asset Turnover | 0.16 | 0.13 | 0.10 | 0.00 | 0.00 | 0.45 | |
| Quick Ratio | 2.29 | 3.29 | 3.39 | 3.74 | 8.50 | 4.15 | |
| Current Ratio | 2.35 | 3.36 | 3.49 | 3.97 | 8.62 | 4.21 | |
| Return on Equity (ROE) | -280.29% | -266.24% | -191.03% | -97.22% | -57.47% | -64.76% | |
| Return on Assets (ROA) | -22.97% | -38.13% | -47.13% | -44.02% | -28.91% | -20.29% | |
| Return on Capital (ROIC) | -83.33% | -107.10% | -88.01% | -52.05% | -33.24% | -39.64% | |
| Earnings Yield | -27.90% | -61.37% | -34.93% | -38.02% | -4.83% | -10.28% | |
| FCF Yield | -35.73% | -61.14% | -8.82% | -31.44% | -4.12% | -24.91% | |
| Buyback Yield / Dilution | -9.52% | -23.98% | -32.69% | -14.79% | -41.37% | -88.83% | |
| Total Shareholder Return | -9.52% | -23.98% | -32.69% | -14.79% | -41.37% | -88.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.